Epoetin alfa prevents, treats chemotherapy-induced anemia

07/19/2013 | MedPage Today (free registration)

Prophylactic epoetin alfa eased anemia during aggressive chemotherapy for breast cancer, a study found. However, 7% of the epoetin alfa-treated patients had thrombotic events, compared with 3% in a control group. "With the exception of this risk, erythropoiesis-stimulating agents appear to be safe drugs for the treatment of chemotherapy-induced anemia or the primary prevention of anemia in patients with intensive dose-dense chemotherapy regimens," according to the report in the Journal of the National Cancer Institute.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Economics & Reimbursement Manager - Transcatheter Heart Valve
Edwards Lifesciences
Irvine, CA
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA